// App-Quantinova.ai

OP0021 (2018) : Draft classification criteria for the anca associated vasculitides

Researchers

Presenter

  • J.C. Robson

Principal Investigators

  • P.C. Grayson

  • C. Ponte

  • R. Suppiah

  • A. Craven

  • S. Khalid

  • A. Judge

  • A. Hutchings

  • D. Gray

  • J. Rosa

  • J. Barrett

  • R.A. Watts

  • P.A. Merkel

  • R. Luqmani

Medical Centers

  • Rheumatology Unit, Faculty of Health and Applied Sciences, University of the West of England, Bristol, Bristol, UK

  • National Institute of Health, Bethesda, MD

  • Lisbon Academic Medical Centre, Lisbon, Portugal

  • Auckland District Health Board, Auckland, New Zealand

  • OCDEM, University of Oxford, Oxford, UK

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United Kingdom

  • United States

  • Portugal

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved